ATR-FTIR spectroscopy detects alterations induced by organotin(IV)
  carboxylates in MCF-7 cells at sub-cytotoxic/-genotoxic concentrations by Ahmad, Muhammad S et al.
ccessOpen AResearch article
ATR-FTIR spectroscopy detects alterations induced by 
organotin(IV) carboxylates in MCF-7 cells at 
sub-cytotoxic/-genotoxic concentrations
Muhammad S Ahmad1,2, Bushra Mirza2, Mukhtiar Hussain3,
Muhammad Hanif 3, Saqib Ali3, Michael J Walsh1 and
Francis L Martin*1
Address: 1Lancaster Environment Centre, Lancaster University, Bailrigg, Lancaster LA1 4YQ, UK, 2Department of Biochemistry,
Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan and 3Department of Chemistry, Quaid-i-Azam
University, Islamabad, Pakistan
Email: Muhammad S Ahmad - sheeraz_qau@yahoo.com; Bushra Mirza - bushra_dr@yahoo.com; 
Mukhtiar Hussain - mukhtiar_chem@yahoo.co.uk; Muhammad Hanif - hanifns@yahoo.com; Saqib Ali - drsa54@yahoo.com; 
Michael J Walsh - m.walsh@lancaster.ac.uk; Francis L Martin* - f.martin@lancaster.ac.uk
* Corresponding author    
Abstract
The environmental impact of metal complexes such as organotin(IV) compounds is of
increasing concern. Genotoxic effects of organotin(IV) compounds (0.01 g/ml, 0.1 g/ml
or 1.0 g/ml) were measured using the alkaline single-cell gel electrophoresis (comet)
assay to measure DNA single-strand breaks (SSBs) and the cytokinesis-block micronucleus
(CBMN) assay to determine micronucleus formation. Biochemical-cell signatures were
also ascertained using attenuated total reflection Fourier-transform infrared (ATR-FTIR)
spectroscopy. In the comet assay, organotin(IV) carboxylates induced significantly-elevated
levels of DNA SSBs. Elevated micronucleus-forming activities were also observed.
Following interrogation using ATR-FTIR spectroscopy, infrared spectra in the
biomolecular range (900 cm-1 – 1800 cm-1) derived from organotin-treated MCF-7 cells
exhibited clear alterations in their biochemical-cell fingerprint compared to control-cell
populations following exposures as low as 0.0001 g/ml. Mono-, di- or tri-organotin(IV)
carboxylates (0.1 g/ml, 1.0 g/ml or 10.0 g/ml) were markedly cytotoxic as determined
by the clonogenic assay following treatment of MCF-7 cells with  1.0 g/ml. Our results
demonstrate that ATR-FTIR spectroscopy can be applied to detect molecular alterations
induced by organotin(IV) compounds at sub-cytotoxic and sub-genotoxic concentrations.
This biophysical approach points to a novel means of assessing risk associated with
environmental contaminants.
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Organometallic compounds are agents that possess bonds between metal and carbon atoms [1].
The organometallic organotin(IV) compounds are characterized by the presence of at least one
covalent C-Sn bond [2]. They contain a tetravalent {Sn} centre and are classified as mono-, di-,
tri- or tetra-organotin(IV)s, depending on the number of alkyl (R) or aryl (Ar) moieties [2]. These
compounds have been well-characterized structurally by infrared (IR), multinuclear NMR (1H,
13C, 119Sn), 119mSn Mossbauer spectroscopy and mass spectrometry [3,4]. Among the organo-
tins, organotin carboxylates are important; these contain a Sn-O bond formed through the COO-
group and exhibit a number of interesting structural features because of the tendency of the ani-
onic group to coordinate inter- or intra-molecularly to tin(IV) [5].
Metal complexes, including organotin(IV) compounds, are used in a number of biomedical
and commercial applications [6-9]. Their structural chemistry has attracted considerable atten-
tion owing to their anti-tumour activity [3,4]. Understanding their mechanism of action may
lead to the development of new anti-tumour drugs as they are less toxic than platinum-based
drugs [10]. Due to the diverse usage of these compounds, organic and inorganic forms of tin have
accumulated in the food chain [10]. These compounds have varying degrees of toxicity, depend-
ing on the nature and number of alkyl groups bonded to the tin atom. Since a number of organ-
otins are toxic [11], there is concern that widespread usage may result in adverse effects within
environmental and biological systems. Exposure to di- or tri-methyl, butyl or phenyl tin induced
aneuploidy in human lymphocyte cultures [12].
Taking into account the structural and biological diversity of organotin(IV) carboxylates [13-
16], we set out to determine whether attenuated total reflection-Fourier-transform infrared (ATR-
FTIR) spectroscopy might be a novel biophysical approach that would allow one to identify
effects associated with typical environmental exposures to mono-, di- and tri-derivatives. In the
oestrogen receptor-positive MCF-7 breast carcinoma cell line, cytotoxicity was ascertained using
the clonogenic assay and, genotoxicity using the alkaline single-cell gel electrophoresis (comet)
assay and the cytokinesis-block micronucleus (CBMN) assay. Although a cancer cell line, MCF-7
cells are robust cell model that have been used to examine genotoxic and toxic effects of candi-
date test agents [17-20]. Because they are metabolically proficient, they are also susceptible to
possible metabolite effects [17,20]. Interrogation of IR spectral characteristics of cellular material
previously exposed to organotin(IV) carboxylates might be a novel and non-destructive method
for screening exposure effects at sub-cytotoxic and sub-genotoxic concentrations. The aim of this
study was to determine whether IR spectra, in the biomolecular range (900 cm-1 – 1800 cm-1),
derived from organotin-treated MCF-7 cells might exhibit molecular alterations compared to
control cells following exposures as low as 0.0001 g/ml; such an approach would highlight the
general and potential applicability of mid-IR spectroscopy to signature toxic effects at sub-lethal
concentrations of compounds. Such a novel biophysical approach might facilitate the determi-
nation of risk posed following typical environmental exposures to environmental contaminants.Page 2 of 19
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Chemicals
Three groups of organotin(IV) carboxylates including mono-, di- and tri-derivatives of ligands
were examined; these included: 3,4-methylenedioxy-6-nitrophenylpropenoic acid (L1), 3,4-
methylenedioxyphenylpropenoic acid (L2) and 2,3-methylenedioxybenzoic acid (L3). The
chemicals were newly synthesized and characterized by elemental analyses, IR spectra, multinu-
clear NMR (1H, 13C, and119Sn) and mass spectroscopy [14,15]. These test agents were previously
investigated for their antibacterial, antifungal, anti-tumour and cytotoxic activities [14,15]. Solid
test agents were dissolved in dimethylsulfoxide (DMSO) and subsequently added to culture
media as solutions in DMSO (maximum concentration 1% v/v). All these compounds are crys-
talline solids, stable in air and soluble in common organic solvents; physical data is shown in
Table 1.
Table 1: Physical data for organotin(IV) derivatives of 3,4-methylenedioxy-6-nitrophenylpropenoic acid (L1), 3,4-
methylenedioxyphenylpropenoic acid (L2) and 2,3-methylenedioxybenzoic acid (L3)
Compound 
no.
General 
Formula
Molecular 
Formula
MolecularWeig
ht
M.P. 
(°C)
Yield 
(%)
Elemental Analysis % Calculated 
(Found)
C H N
Ligand 1 (L1) C10H7O6N 237 278 80 50.63 
(50.45)
2.95 
(2.80)
5.91 
(5.87)
1 Bu3Sn(L1) C22H33O6NSn 527 143–146 89 50.09 
(50.23)
6.26 
(6.30)
2.65 
(2.70)
2 BuSnCl(L1)2 C24H21O12N2SnC
l
684.5 142–145 70 42.07 
(42.24)
3.07 
(3.15)
4.09 
(4.04)
3 Ph3Sn(L1) C28H21O6NSn 587 207–210 80 57.24 
(54.43)
3.58 
(3.60)
2.38 
(2.45)
4 Bu2Sn(L1)2 C28H30O12N2Sn 706 196–199 73 47.60 
(47.74)
4.25 
(4.16)
3.97 
(4.01)
Ligand 2 (L2) C10H8O4 192 238 90 62.50 
(62.30)
4.17 
(4.23)
-
5 Et2Sn(L2)2 C24H24O8Sn 560 177–179 81 51.43 
(51.39)
4.28 
(4.24)
-
6 Me2Sn(L2)2 C22H20O8Sn 532 247–248 73 49.62 
(49.98)
3.76 
(3.70)
-
7 Ph3Sn(L2) C28H22O4Sn 542 180–181 84 61.99 
(62.25)
4.06 
(3.98)
-
8 Bu2Sn(L2)2 C28H32O8Sn 616 134–136 68 54.54 
(54.68)
5.19 
(5.08)
-
Ligand 3 (L3) C8H6O4 166 165 65 57.83 
(57.72)
3.61 
(3.70)
-
9 Bu2Sn(L3)2 C24H28O8Sn 564 180–184 78 51.06 
(51.20)
4.96 
(5.01)
-
10 BuSn(L3)3 C28H24O12Sn 672 220–222 74 50.0 (50.10) 3.57 
(3.58)
-
11 Me3Sn(L3) C11H14O4Sn 330 150–151 68 40.0 (41.8) 4.24 
(4.01)
-
12 Et2Sn(L3)2 C20H20O8Sn 508 210–215 80 47.24 
(47.23)
3.94 
(3.81)
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The human mammary carcinoma MCF-7 cell line was grown in complete medium comprising
Dulbecco's modified essential medium (DMEM) supplemented with 10% heat-inactivated foetal
calf serum, penicillin (100 U/ml) and streptomycin (100 g/ml) [17,18]. Cells were grown in 5%
CO2 in air at 37°C in a humidified atmosphere and disaggregated using a trypsin (0.05%)/EDTA
(0.02%) solution, to form single-cell suspensions prior to sub-culture or incorporation in exper-
iments [18].
The clonogenic assay
Test agents were examined at three concentrations (0.1 g/ml, 1.0 g/ml and 10.0 g/ml) with
DMSO as vehicle control. Aliquots of  0.5 × 103 MCF-7 cells in 5 ml complete medium were
exposed to the various treatments in T25 flasks [17,19,20]. Cells were exposed under incubation
conditions of 5% CO2 in air at 37°C in a humidified atmosphere for 24 h, after which medium
was replaced with fresh medium [19]. Cells were then cultured for a further 7-day period, where-
upon they were fixed with 70% ethanol (EtOH) and stained with 5% Giemsa; visible colonies
were subsequently scored [17,19,20]. Results are presented as the mean ± SD of the average val-
ues derived from triplicate measurements for each treatment condition in three independent
experiments.
The alkaline single-cell gel electrophoresis (Comet) assay
Microscope slides were cleaned with 70% EtOH and pre-coated on one side with a 1% solution
of normal melting point (NMP) agarose in H2O [21]. MCF-7 cells grown to confluence in 12-well
multi-well dishes were exposed in 1 ml of complete medium to various concentrations (0.01 g/
ml, 0.1 g/ml and 1.0 g/ml final concentrations) of test compound added as a solution in
DMSO; DMSO was employed as the vehicle control and 1.0 M benzo[a]pyrene (B[a]P) as pos-
itive control [21,22]. Subsequent steps were carried out under a darkened environment. After 2-
h exposure, cells were disaggregated with trypsin/EDTA solution and re-suspended in 1 ml phos-
phate-buffered saline (PBS). To this, an equal volume of a warm ( 37°C) 1% solution of low
melting point (LMP) agarose in PBS was added. A 150-l aliquot containing  5 × 104 cells was
added to coded slides. This LMP agarose layer was evenly spread through the application of a cov-
erslip and allowed to set for 5 min on a cold surface. Coded slides were then submerged over-
night in cold (4°C) lysis solution [buffer (2.5 M NaCl, 100 mM EDTA disodium salt, 10 mM Tris,
1% N-lauroyl sarcosine; adjusted to pH 10 with NaOH) with 1% Triton X-100 and 10% DMSO
added prior to use] [22]. The slides were then transferred to a horizontal electrophoresis tank,
covered in electrophoresis solution (0.3 M NaOH, 1 mM EDTA, pH > 13), and stored for 35 min
at 10°C prior to electrophoresis at 0.8 V/cm and 300 mA for 35 min [21-23]. After electrophore-
sis, slides were neutralized with neutralization buffer (pH 7.5) and stained with ethidium bro-
mide (20 ng/ml) after which comet-forming activity was scored by epifluorescence using a Leitz
Dialux 20 EB microscope. Analyses for comet tail length (CTL; m), % Tail DNA (% T DNA) and
Olive tail moment (OTM) were performed using Comet IV software [23,24]. From duplicatePage 4 of 19
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independently twice.
The cytokinesis-block micronucleus (CBMN) assay
MCF-7 cells were re-suspended in fresh complete medium and 3-ml aliquots ( 1 × 104 cells)
were seeded into Petri dishes containing 20 mm coverslips (Sarstedt, UK) [17]. After a 24-h incu-
bation to allow attachment, cells were than exposed to test agents (0.01 g/ml, 0.1 g/ml and 1.0
g/ml), as indicated; an equal volume of DMSO was employed as vehicle control and B[a]P (1.0
M) as a positive control. Following a 24-h exposure, medium was replaced with fresh medium
without treatment but containing 2 g/ml cytochalasin-B [17,25]. The dishes were incubated for
a further 24 h, whereupon cells were fixed with 70% EtOH and stained with 5% Giemsa. For each
cell population examined, micronuclei in 1,000 binucleate MCF-7 cells, total number of micro-
nuclei in 1,000 binucleate MCF-7 cells and the distribution of multiple micronuclei ( 5) in
1,000 binucleate MCF-7 cells was ascertained [17,25].
Attenuated total reflection-Fourier-transform infrared (ATR-FTIR) spectroscopy
MCF-7 cells (1/6th of a confluent T75 flask in 6 ml complete medium) were cultured in 60-mm
tissue culture dishes for 24 h prior to being treated with test compounds (0.0001 g/ml, 0.01 g/
ml or 1.0 g/ml); DMSO was employed as a vehicle control [19]. After 24-h exposure, cells were
disaggregated with trypsin/EDTA solution, fixed in 70% EtOH, and applied to Low-E Microscope
slides whereupon the suspensions were allowed to air-dry. Samples were then stored in a desic-
cated environment prior to analysis. IR spectra were acquired using a Bruker Vector 22 FTIR spec-
trometer with Helios ATR attachment that contained a diamond crystal (Bruker Optics, USA)
[19]. Using a closed circuit television (CCTV) camera attached to the ATR crystal, ten random
locations were interrogated across the samples [18]. Spectra were collected in ATR mode (8 cm-1
spectral resolution, co-added for 32 scans) and were converted into absorbance using Bruker
OPUS software. Sodium dodecyl sulfate (Sigma Chemical Co., UK) was used to clean the ATR
crystal after analysis of each sample. Each time the crystal was cleaned, a new background reading
was taken before recommencing spectral analysis. Spectra were baseline corrected and normal-
ized to Amide I ( 1650 cm-1) absorbance band using OPUS software [26]. IR spectra (900 cm-1
– 1800 cm-1) were analysed employing principal component analysis (PCA) using the Pirouette
software package (Infometrix, USA) [27]. In PCA, each spectrum becomes a single point or score,
in n-dimensional space and using selected principal components (PCs) as coordinates, the data
was analysed for clustering when viewed in different directions. A 3-D scores plot on PCs selected
to demonstrate best segregation of cell spectra from different treatment groups was obtained;
derived loadings plots highlighted the wavenumbers contributing to variance [26,27].Page 5 of 19
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The clonogenic assay
The effects of organotin(IV) derivatives on the colony-forming ability of MCF-7 cells were ascer-
tained (Figure 1). With all the test agents examined, dose-related decreases in colony formation
were noted. Organotin(IV) derivatives of 3,4-methylenedioxy-6-nitrophenylpropenoic acid (L1)
were the tri-organotin carboxylates Bu3Sn(L1) and Ph3Sn(L1) which were 100% toxic at  1.0 g/
ml, the di-organotin Bu2Sn(L1)2 which was 100% toxic at  10.0 g/ml and the mono-organotin
carboxylate BuSnCl(L1) which was the least toxic in this series. The cytotoxicity of organotin(IV)
derivatives of 3,4-methylenedioxyphenylpropenoic acid (L2) also increased in a dose-related
fashion. The tri-organotin carboxylates Ph3Sn(L2) was 100% toxic at  1.0 g/ml whereas the di-
organotin Bu2Sn(L2)2 was only toxic at  1.0 g/ml. Dose-related increases in the toxicities of
organotin(IV) derivatives of 2,3-methylenedioxybenzoic acid (L3) were also observed (Figure 1).
Following 24-h exposure to di-organotin carboxylates Bu2Sn(L3)2 or Et2Sn(L3)2, 100% cytotox-
icity was noted  1.0 g/ml whereas the mono-organotin BuSn(L3)3 was far less toxic. Surpris-
ingly, in this series the least cytotoxic test agent was Me3Sn(L3). Each class of organotin(IV)
derivative exhibited cytotoxicity following 24-h exposure in MCF-7 cells. In general, tri-organo-
tins were more toxic than di-organotins with mono-derivative exhibiting the least toxicity in this
assay.
Micronucleus-forming activity
The micronucleus-forming activities of organotin(IV) carboxylates was assessed at three concen-
trations (Figure 2). Following 24-h exposure to all test agents, elevations in levels of micronuclei
induced were observed. In the absence of cytotoxicity (Figure 1), micronucleus-forming activity
was dose-related. Test agents such as Bu3Sn(L1), Ph3Sn(L1) and Ph3SnCl(L1) were all micronu-
cleus-forming at the lowest concentration of 0.01 g/ml, but higher concentrations were cytox-
oxic. With a number of test agents including Me2Sn(L1)2, Ph3Sn(L2), Et2Sn(L3)2, Bu2Sn(L1)2,
Me2Sn(L2)2, Ph3Sn(L2), BuSn(L3)2 and Et2Sn(L3)2, a reversal in elevated micronucleus forma-
tion induced by lower exposures was noted in the presence of higher cytotoxic concentrations
(Figure 2). Only the relatively non-cytotoxic organotin(IV) carboxylates including BuSnCl(L1),
Et2Sn(L2)2, Me2Sn(L2)2, Bu2Sn(L2)2 and Me3Sn(L3) exhibited micronucleus-forming activity
throughout the concentration range tested; the least micronucleus-forming derivative was
BuSn(L3)3 (Figure 2). These results suggest that following 24-h exposure to  0.1 g/ml tri-orga-
notins [Bu3Sn(L1), Ph3Sn(L1) or Ph3Sn(L2)] except for Me3Sn(L3), cytotoxic effects were more
important. Following exposure to di-organotins [Bu2Sn(L1)2, Et2Sn(L2)2, Bu2Sn(L3)2 or
Et2Sn(L3)2] with the exception this time being Bu2Sn(L2)2, cytotoxicity was the more important
endpoint with  1.0 g/ml. However, with the less cytotoxic mono-organotins [BuSnCl(L1)2 and
BuSn(L3)3], elevated micronucleus formation was noted up to 10.0 g/ml. In general, micronu-
cleus-forming activity was of the order of mono- > di- > tri-organotin.Page 6 of 19
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Effects of organotin(IV) carboxylates on per cent survival in MCF-7 cellsFigure 1
Effects of organotin(IV) carboxylates on per cent survival in MCF-7 cells. Cells (0.5 × 103 cells) were seeded in 25 
cm2 flasks in the presence or absence of test agent and incubated for 24 h, as described in Materials and methods. 
Following addition of fresh medium, in the absence of exposure, cells were cultured undisturbed at 37°C and 5% 
CO2 in a humidified atmosphere for 7 days. Surviving colonies were fixed and stained, and per cent survival was cal-
culated by estimating the percentage of colonies counted over the number of cells initially seeded. Results are pre-
sented as the mean ± SD of the average values derived from triplicate measurements for each treatment condition 
in three independent experiments.
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Except for instances where there was marked toxicity [e.g., following 2-h exposure to 1.0 g/ml
Et2Sn(L3)2], all the organotin(IV) carboxylates were significantly (P < 0.0001) comet-forming as
evidenced by an elevation of DNA SSBs determined by the alkaline comet assay (Table 2; Figure
3). Table 2 shows the comet-forming activities of organotin(IV) carboxylates derivatives in terms
of CTL, %T DNA and OTM. MCF-7 cells were exposed for 2 h to either vehicle control (DMSO),
three concentrations of test agent (0.01 g/ml, 0.1 g/ml or 1.0 g/ml) or positive control (1.0
M B[a]P). The results are a taken from a total of 400 randomly-selected nuclei from duplicate
slides (i.e., 100 nuclei scored per slide) and two independent experiments. Throughout all the
Micronucleus-forming activity of organotin(IV) carboxylates following 24-h exposure of MCF-7 cellsFigure 2
Micronucleus-forming activity of organotin(IV) carboxylates following 24-h exposure of MCF-7 cells. Cells were 
seeded as 3-ml aliquots ( 1 × 104 cells) into 30 mm Petri dishes as described in Materials and methods. Following 
exposure the cells were blocked at cytokinesis by addition of fresh medium containing 2 g cytochalasin B/ml. Cells 
were cultured for a further 24 h prior to fixation and staining with 5% Giemsa. Micronucleus formation was scored 
in 1,000 binucleate cells. In a corresponding control experiment, 1 M benzo[a]pyrene induced a score of 255 
micronucleated and 466 (the distribution being 135, 71, 28, 14, 7) total number of micronuclei in 1,000 binucleate 
MCF-7 cells. This compared to levels in vehicle control cells of 149 micronucleated and 219 (the distribution being 
101, 30, 15, 2, 1) total number of micronuclei in 1,000 binucleate MCF-7 cells.
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Comet-forming activity of organotin(IV) carboxylates in MCF-7 cellsFigure 3
Comet-forming activity of organotin(IV) carboxylates in MCF-7 cells. Cells were grown to confluence in 12-well 
multi-well dishes and were exposed in 1 ml of complete medium to various concentrations (0.01 g/ml, 0.1 g/ml 
and 1.0 g/ml final concentrations) of test agent added as a solution in DMSO; DMSO was employed as the vehicle 
control and 1.0 M B[a]P as positive control. Following a 2-h exposure, cells were disaggregated with trypsin/EDTA 
prior to incorporation into the alkaline comet assay as described in the Materials and methods. As a measure of 
DNA damage, % Tail DNA (% T DNA) was used; for other measures of DNA damage including comet tail length 
(CTL; m), and Olive tail moment (OTM), see Additional file 1.
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PMC Biophysics 2008, 1:3 http://www.physmathcentral.com/1757-5036/1/3experiments conducted, B[a]P was consistently and significantly (P < 0.0001) comet-forming.
Although there were marked fluctuations in the background levels of DNA SSBs measurable in
control MCF-7 cell populations, a remarkable consistency in the ability of all the organotin(IV)
Table 2: Comet-forming activities of organotin(IV) derivatives
Compound Comet Analysis Mean ± 95% CI
Vehicle control 0.01 g/ml 0.1 g/ml 1.0 g/ml B [a]P (1.0 M)
1 Bu3Sn(L1) CTL (m) 38.7 ± 1.4 49.5 ± 2.0*** 50.1 ± 1.7*** 40.9 ± 1.8 47.6 ± 1.6***
% T DNA 1.5 ± 0.4 4.4 ± 0.9*** 7.4 ± 1.5*** 9.9 ± 1.2*** 4.7 ± 1.0***
OTM 0.3 ± 0.1 1.3 ± 0.4*** 2.1 ± 0.6*** 2.0 ± 0.4*** 1.4 ± 0.5***
2 BuSnCl(L1)2 CTL (m) 29.7 ± 0.9 39.5 ± 1.1*** 40.7 ± 1.2*** 38.3 ± 1.1*** 44.7 ± 1.4***
% T DNA 1.8 ± 0.5 7.6 ± 1.4*** 6.5 ± 0.3*** 8. 5 ± 1.4*** 8.9 ± 1.6***
OTM 0.3 ± 0.1 1.5 ± 0.3*** 1.4 ± 0.3*** 1.6 ± 0.3*** 2.1 ± 0.5***
3 Ph3Sn(L1) CTL (m) 41.7 ± 2.3 52.9 ± 2.7*** 51.1 ± 2.4*** 48.9 ± 2.8*** 56.8 ± 2.9***
% T DNA 3.5 ± 0.6 8.3 ± 1.4*** 9.3 ± 1.4*** 10.4 ± 1.7*** 12.68 ± 1.8***
OTM 0.9 ± 0.2 2.8 ± 0.8*** 2.7 ± 0.6*** 3.5 ± 0.9*** 4.0 ± 0.9***
4 Bu2Sn(L1)2 CTL (m) 29.7 ± 0.9 41.4 ± 1.0*** 40.65 ± 1.1*** 38.0 ± 1.1*** 44.7 ± 1.4***
% T DNA 1.8 ± 0.5 7.0 ± 1.2*** 7.55 ± 1.2*** 6.2 ± 1.2*** 8.9 ± 1.6***
OTM 0.3 ± 0.1 1.4 ± 0.3*** 1.49 ± 0.3*** 1.2 ± 0.2*** 2.1 ± 0.5***
5 Et2Sn(L2)2 CTL (m) 33.7 ± 0.9 36.98 ± 1.1*** 39.8 ± 1.3*** 39.7 ± 1.1*** 41.0 ± 1.5***
% T DNA 2.7 ± 0.7 4.91 ± 0.99** 6.2 ± 1.2*** 6.3 ± 1.2*** 7.1 ± 1.4***
OTM 0.5 ± 0.1 1.06 ± 0.3*** 1.4 ± 0.3*** 1.3 ± 0.3*** 1.9 ± 0.5***
6 Me2Sn(L2)2 CTL (m) 30.2 ± 0.8 34.2 ± 1.1*** 35.6 ± 1.2*** 34.3 ± 1.0*** 36.6 ± 1.2***
% T DNA 0.8 ± 0.3 4.8 ± 1.1*** 6.5 ± 1.2*** 4.5 ± 1.1*** 4.6 ± 0. 9***
OTM 1.1 ± 0.04 1.0 ± 0.3*** 1.4 ± 0.5*** 0.9 ± 0.2*** 1.0 ± 0.2***
7 Ph3Sn(L2) CTL (m) 30.2 ± 0.8 35.9 ± 1.1*** 37.8 ± 1.2* 32.4 ± 1.1* 36.6 ± 1.15***
% T DNA 0.8 ± 0.3 4.9 ± 1.1*** 4.4 ± 1.2*** 4.7 ± 1.1*** 4.6 ± 0.9***
OTM 1.1 ± 0.04 1.0 ± 0.2*** 1.2 ± 0.5*** 0.9 ± 0.2*** 1.0 ± 0.9***
8 Bu2Sn(L2)2 CTL (m) 41.7 ± 2.3 51.4 ± 2.4*** 52.2 ± 2.4*** 55.2 ± 2.9*** 56.8 ± 3.0***
% T DNA 3.5 ± 0.6 8.9 ± 1.4*** 8.6 ± 1.3*** 9.4 ± 1.2*** 12.6 ± 1.8***
OTM 0.9 ± 0.2 2.7 ± 0.6*** 2.4 ± 0.5*** 2.6 ± 0.5*** 4.0 ± 0.9***
9 Bu2Sn(L3)2 CTL (m) 37.5 ± 1.2 40.5 ± 1.3 39.4 ± 1.5 34.5 ± 1.3* 50.0 ± 2.0***
% T DNA 3.9 ± 0.85 5.3 ± 1.0 6.2 ± 1.1* 5.8 ± 1.2* 9.0 ± 1.7***
OTM 0.8 ± 0.2 1.1 ± 0.4 1.5 ± 0.4* 1.2 ± 0.31* 3.2 ± 0.4***
10 BuSn(L3)3 CTL (m) 38.7 ± 1.4 45.8 ± 1.7*** 45.2 ± 1.4*** 44.8 ± 1.6*** 47.6 ± 1.6***
% T DNA 1.5 ± 0.4 5.0 ± 1.0*** 5.2 ± 1.1*** 5.2 ± 1.2*** 4.7 ± 1.0***
OTM 0.3 ± 0.1 1.3 ± 0.3*** 1.3 ± 0.4*** 1.4 ± 0.6*** 1.4 ± 0.5***
11 Me3Sn(L3) CTL (m) 33.7 ± 1.1 39.7 ± 1.3*** 44.9 ± 1.3*** 41.8 ± 1.2*** 41.0 ± 1.5***
% T DNA 2.7 ± 0.7 6.4 ± 1.2*** 5.8 ± 1.2*** 6.0 ± 0.1*** 7.1 ± 0.4***
OTM 0.5 ± 0.1 1.4 ± 0.3*** 1.5 ± 0.4*** 1.3 ± 0.3*** 1.9 ± 0.5***
12 Et2Sn(L3)2 CTL (m) 37.5 ± 1.2 42.1 ± 1.2*** 40.8 ± 1.4** 36.6 ± 1.4 50.0 ± 2.0***
% T DNA 3.9 ± 0.85 5.2 ± 1.07 5.9 ± 1.2* 6.4 ± 1.16** 9.0 ± 1.7***
OTM 0.8 ± 0.2 1.3 ± 0.3 1.4 ± 0.4* 1.4 ± 0.3** 3.2 ± 0.4***
*** P < 0.0001; ** P < 0.001; * P < 0.01Page 10 of 19
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PMC Biophysics 2008, 1:3 http://www.physmathcentral.com/1757-5036/1/3carboxylates to be comet-forming was noted (Figure 3; see Additional file 1). Following treat-
ment with some organotin(IV) carboxylates [e.g., Bu3Sn (L1), Ph3Sn(L1), Ph3Sn(L2),
Bu2Sn(L3)2], it may be that comet formation is being replaced by cytoxicity at the 1.0 g/ml
exposure level. However, in the presence of less toxic derivatives [e.g., BuSnCl(L1)2, Et2Sn(L2)2,
Me3Sn(L3)], Figure 3 does point to evidence of dose-related increases in formation of DNA SSBs.
At all the concentrations tested, levels of DNA SSBs induced were not dissimilar to those observed
following treatment with the positive control. However, with the alkaline comet assay it was
more difficult to distinguish between the relative abilities of tri-organotin carboxylates, di-orga-
notin carboxylates or mono-organotin carboxylates to induce elevations in DNA SSBs.
A biochemical-cell fingerprint
The effects of 24-h exposure of MCF-7 cells with 0.0001 g/ml Bu3Sn(L1) (a mono-organotin car-
boxylate) (Figure 4), Ph3Sn(L2) (a di-organotin carboxylate) (Figure 5) or Me3Sn(L3) (a tri-orga-
notin carboxylate) (Figure 6) on the consequent IR spectrum of 70% EtOH-fixed cellular
material, compared to vehicle control are shown. To see effects induced by all the organotin(IV)
carboxylates tested at all exposures (0.0001 g/ml, 0.01 g/ml or 1.0 g/ml), see Additional file
1. Following fixation, MCF-7 cells were applied to Low-E reflective glass slides and interrogated
using the  250 m × 250 m octagon-shaped sampling area employed in this study for ATR-FTIR
spectroscopy [18]. An IR spectrum of cellular biochemistry was obtainable from such 70% EtOH-
fixed cells [19]. In the biomolecular region (900 cm-1 – 1800 cm-1), clear induced alterations in
the "biochemical-cell fingerprint" were associated with organotin-treated cells (Figures 4, 5, 6;
see Additional file 1). In this study, variability was noted in control spectra between 1400 cm-1
and 1500 cm-1; however, in order to distinguish intra-class differences (i.e., vehicle control vs.
treatment) one needs to look at the direction of the PCs. The most marked differences were noted
in the spectral region  1300 cm-1 – 1500 cm-1; these would be associated with amide III absorp-
tions (predominantly C-N stretching) with significant contributions from CH2 stretching vibra-
tions of carbohydrate residues ( 1280 cm-1 – 1360 cm-1), but some of these wavenumbers would
be associated with intra-class as opposed to inter-class variance (Figures 4, 5, 6). However, in Fig-
ure 5 PC1 mostly excludes this aforementioned region as a contributor to variance but highlights
1225 cm-1 (asymmetric phosphate), which consistently contributed to variance. Additionally, in
some cases [Bu2Sn(L1)2, Et2Sn(L2)2, Me2Sn(L2)2, BuSn(L3)3 and Me3Sn(L3)], glycogen ( 1030
cm-1) was observed as an important contributing factor. Of note was the fact that except for BuS-
nCl(L1)2, separation of IR spectra derived from 0.0001 g/ml exposed and control MCF-7 cells
was readily achievable along PCs 1, 2 and 3 (see Additional file 1). This suggested that organo-
tin(IV) carboxylates (tri-, di- or mono-derivatives) are capable of inducing profound biomolecu-
lar alterations even at low concentrations.Page 11 of 19
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Average IR spectra of MCF-7 cells with corresponding scores plots plotted on PCs 1, 2 and 3 and loadings plots fol-lowing 24-h exposure to 0.0001 g Bu3Sn(L1)/mlFigure 
Average IR spectra of MCF-7 cells with corresponding scores plots plotted on PCs 1, 2 and 3 and loadings plots fol-
lowing 24-h exposure to 0.0001 g Bu3Sn(L1)/ml. Cells were seeded into 60-mm Petri dishes and allowed to attach 
for 24 h prior to exposure. Following exposure, cells were disaggregated with trypsin/EDTA solution, fixed in 70% 
EtOH, and applied to Low-E Microscope slides whereupon the suspensions were allowed to air-dry. A) 10 IR spec-
tra were derived (vehicle control in blue, treated in red). B) From subsequent multivariate analysis, a 3-D scores 
plot on PCs selected to demonstrate best segregation of vehicle control (blue) vs. exposure (red) was constructed. 
C) Following cluster analysis, loadings plots were constructed on each relevant PC to identify the wavenumbers 
most responsible for segregation of clusters.
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Average IR spectra of MCF-7 cells with corresponding scores plots plotted on PCs 1,2 and 3 and loadings plots fol-lowing 24-h exposure to 0.0001 g Ph3Sn(L2)/mlFigure 5
Average IR spectra of MCF-7 cells with corresponding scores plots plotted on PCs 1,2 and 3 and loadings plots fol-
lowing 24-h exposure to 0.0001 g Ph3Sn(L2)/ml. Cells were seeded into 60-mm Petri dishes and allowed to attach 
for 24 h prior to exposure. Following exposure, cells were disaggregated with trypsin/EDTA solution, fixed in 70% 
EtOH, and applied to Low-E Microscope slides whereupon the suspensions were allowed to air-dry. A) 10 IR spec-
tra were derived (vehicle control in blue, treated in red). B) From subsequent multivariate analysis, a 3-D scores 
plot on PCs selected to demonstrate best segregation of vehicle control (blue) vs. exposure (red) was constructed. 
C) Following cluster analysis, loadings plots were constructed on each relevant PC to identify the wavenumbers 
most responsible for segregation of clusters.
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Average IR spectra of MCF-7 cells with corresponding scores plots plotted on PCs 1,2 and 3 and loadings plots fol-lowing 24-h exposure to 0.0001 g Me3Sn(L3)/mlFigure 6
Average IR spectra of MCF-7 cells with corresponding scores plots plotted on PCs 1,2 and 3 and loadings plots fol-
lowing 24-h exposure to 0.0001 g Me3Sn(L3)/ml. Cells were seeded into 60-mm Petri dishes and allowed to attach 
for 24 h prior to exposure. Following exposure, cells were disaggregated with trypsin/EDTA solution, fixed in 70% 
EtOH, and applied to Low-E Microscope slides whereupon the suspensions were allowed to air-dry. A) 10 IR spec-
tra were derived (vehicle control in blue, treated in red). B) From subsequent multivariate analysis, a 3-D scores 
plot on PCs selected to demonstrate best segregation of vehicle control (blue) vs. exposure (red) was constructed. 
C) Following cluster analysis, loadings plots were constructed on each relevant PC to identify the wavenumbers 
most responsible for segregation of clusters.
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PMC Biophysics 2008, 1:3 http://www.physmathcentral.com/1757-5036/1/3PCA is employed as a multivariate technique to reduce the number of correlated variables (i.e.,
IR spectra) to a smaller number of independent variables, known as PCs that account for the
majority of the variance of the original data; this thereby reduces its dimensionality. Taking IR
spectra derived from cellular material previously exposed to Bu2Sn(L1)2, it was notable to see
that one could cluster the dose-related effects of this test agent (Figure 7). A scores plot along PCs
1, 2 and 3 was constructed and rotation allowed selection of the view that highlighted best seg-
regation (i.e., vehicle control vs. 0.0001 g/ml vs. 0.01 g/ml vs. 1.0 g/ml organotin(IV) carbox-
ylate). In such a scores plot, nearness in space implies similarity whilst distance points to
segregation in the derived IR spectral fingerprint of the interrogated cellular material. PC1 is
defined in the direction of maximum variance of the whole data set whilst PC2 is the direction
3-D scores plot on PCs selected to demonstrate best segregation of MCF-7 cell IR spectra derived following 24-h exposure to Bu2S (L1)2, as indica edFigure 7
3-D scores plot on PCs selected to demonstrate best segregation of MCF-7 cell IR spectra derived following 24-h 
exposure to Bu2Sn(L1)2, as indicated. IR spectra were collected using ATR-FTIR spectroscopy. Each spectrum was 
expressed in terms of chosen PCs using Pirouette software and rotated to identify segregation of different clusters. 
Each symbol represents a single spectrum as a single point in "hyperspace". The 3-D scores plot represents the seg-
regation of cell populations following different exposures (i.e., vehicle control vs. 0.0001 g/ml vs. 0.01 g/ml vs. 1.0 
g/ml organotin(IV) carboxylate) on PC1, PC2 and PC3.
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PMC Biophysics 2008, 1:3 http://www.physmathcentral.com/1757-5036/1/3that describes the maximum variance in the orthogonal subspace to PC1. Subsequent PCs are
taken orthogonal to those previously chosen and describe the maximum of the remaining vari-
ance. Generally, only the first few PCs are required to describe most of the information contained
in the original data set. Figure 7 strongly supports the notion that ATR-FTIR spectroscopy com-
bined with multivariate analysis is a powerful new approach for identifying exposure effects in
target cell populations.
Discussion
The acute effects of organotin(IV) compounds, used as biocides against a number of organisms,
have been extensively investigated [2]. Their mechanism of toxicity remains obscure. It is
assumed that these compounds are capable of reacting with cell membranes leading to leakage,
accelerating ion exchange processes, and inhibiting oxidative or photochemical phosphoryla-
tion. Among RnSnX(4-n) compounds, the most toxic appear to be the R3SnX [2,28,29]. In this
study, we set out to apply ATR-FTIR spectroscopy in order to ascertain whether IR spectra, in the
biomolecular range (900 cm-1 – 1800 cm-1), derived from organotin-treated MCF-7 cells might
exhibit molecular alterations compared to control cells following exposures to sub-cytotoxic and
sub-genotoxic concentrations of test agent. Effects of a panel of mono-, di- or tri-organotin(IV)
carboxylates in MCF-7 cells were examined. Cytotoxicity was assessed in the clonogenic assay
whilst genotoxicity was determined using the CBMN and alkaline comet assays.
In the 0.01 g/ml to 10.0 g/ml concentration range, all the organotin(IV) carboxylates tested
induced clear dose-related increases in cytotoxicity (Figure 1). However, with six of the deriva-
tives [BuSnCl(L1)2, Et2Sn(L2)2, Me2Sn(L2)2, BuSn(L3)3 and Me3Sn(L3)] >60% survival was still
observed following 24-h exposure to 10.0 g/ml. In line with these observations, we examined
the ability of the test agents to induce elevated levels of micronuclei or DNA SSBs (Figures 2 and
3). Even at the lowest concentration of 0.01 g/ml, marked elevations in micronucleus formation
[except for BuSn(L3)3] and significant (P < 0.0001) increases in DNA SSBs [except for
Bu2Sn(L3)2] were induced following either 24-h or 2-h exposures, respectively. At higher concen-
trations of test agent, apparent reversals in the induction of genotoxic effects were probably asso-
ciated with cytotoxicity. An example of this was the dose related effects of BuSnCl(L1)2; in the
CBMN assay (Figure 2) and the alkaline comet assay there are elevations in genotoxicity with
increasing concentration up to 0.1 g/ml. However, at the higher 1.0 g/ml concentration there
is an apparent falling off in the levels of micronucleus formation (Figure 2) or DNA SSBs (Table
2). Although not as marked as with other organotin(IV) carboxylates, there is a measurable cyto-
toxic effect in MCF-7 cells associated with this concentration of test agent.
One might surmise that environmental effects of such agents might be a consequence of expo-
sures an order-of-magnitude or more lower than those routinely used in short-term (geno)toxic-
ity assays. The requirement for an appropriate concentration range in order to detect measurable
effects in such assays is a major limitation as it is then difficult to make meaningful extrapola-Page 16 of 19
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PMC Biophysics 2008, 1:3 http://www.physmathcentral.com/1757-5036/1/3tions to lower but more environmentally-relevant concentrations. To this end, we applied ATR-
FTIR spectroscopy to ascertain whether IR spectral changes might be identifiable in cells exposed
to concentrations as low as 0.0001 g/ml (Figures 4, 5, 6). Following IR spectral interrogation of
treated vs. vehicle control cells, PCA was used to derive scores plots along PCs 1, 2 and 3. Except
for two of the test agents [BuSnCl(L1)2 and Bu2Sn(L2)2], marked separation of vehicle control vs.
treatment clusters was observed (see Additional file 1). In the loadings plots along the PCs used,
there was a consistency in the identification of peaks in the spectral region  1300 cm-1 – 1500
cm-1 as being the predominant contributors to variance segregating the clusters. These loadings
would be associated with amide III absorptions (predominantly C-N stretching) with significant
contributions from CH2 stretching vibrations of carbohydrate residues ( 1280 cm-1 – 1360 cm-
1) (Figures 4, 5, 6). However, PC1 often seemed most responsible for inter-class variance and
pointed to wavenumbers primarily associated with DNA/RNA conformational changes e.g., 1225
cm-1. Identifying wavenumbers responsible for inter-class variance would be important as these
might give a signature of low-dose toxic effects associated with organotin(IV) carboxylates [19].
Di-n-butyltin and tri-n-butyltin chloride are known to induce apoptosis in vitro in rat thymo-
cytes [30,31]. The apoptotic pathway induced starts with an increased influx of Ca2+ ions and is
followed by the release of the cytochrome c from mitocondria, activation of caspases and finally
DNA fragmentation [31]. Diethyltindichloro(1,10-phenanthroline) inhibits cancer cell growth
and also alters the surface of the cancer cell membrane [32,33]. The binding efficiency to DNA
of organotin compounds depends on the coordination number and nature of groups bonded to
the central tin atom [32]. The phosphate group of the DNA sugar backbone usually acts as an
anchoring site and often results in the stabilization of the tin centre as an octahedral stable spe-
cies [32,33].
Organotin(IV) compounds may have applications in cancer chemotherapy [32,34-38].
Recently, thirty interesting inorganic pharmaceuticals, four of which are tin compounds
[32,33,39] have been described. If such agents have significant usage, it will be important to be
able to identify measurable effects following low-level exposures to such potentially highly toxic
derivatives.
Conclusion
Ascertaining the biological effects of environmental contaminants, especially if their cell or intra-
cellular targets are unknown, remains a difficult challenge. Conventional cell-biology assays gen-
erally measure a single end-effect (e.g., cytotoxicity, micronucleus formation or comet-forming
activity). Concentrations much higher than those generally found in the environment are usually
required to induce such end-effects and one needs to extrapolate from such experimental set-
tings. However, our study demonstrates that ATR-FTIR spectroscopy can be used to identify sig-
nature biological effects at concentrations much lower than those required to induce cytotoxicityPage 17 of 19
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PMC Biophysics 2008, 1:3 http://www.physmathcentral.com/1757-5036/1/3or genotoxicity. Application of this biophysical approach is a novel means of assessing risk asso-
ciated with environmental contaminants. Whether the induced IR spectral alterations observed
are a signature of exposure to organotin(IV) carboxylates or a more general molecular alteration
in response to environmental contaminants will be examined by comparing the biochemical-cell
fingerprints of different classes of environmental contaminants.
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